{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "22814842", "DateCompleted": {"Year": "2013", "Month": "08", "Day": "19"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.dsx.2010.05.014"], "ArticleDate": [{"Year": "2010", "Month": "06", "Day": "07"}], "Journal": {"ISSN": "1878-0334", "JournalIssue": {"Volume": "5", "Issue": "1", "PubDate": {"Year": "2011", "Season": "Jan-Mar"}}, "Title": "Diabetes & metabolic syndrome", "ISOAbbreviation": "Diabetes Metab Syndr"}, "ArticleTitle": "Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy.", "Pagination": {"StartPage": "45", "EndPage": "49", "MedlinePgn": "45-9"}, "Abstract": {"AbstractText": ["It is now well established that hyperglycemia, present in both type 1 and type 2 diabetes, causes a variety of biochemical derangements leading to a diffused vascular damage responsible for several pathologic manifestations. Although preclinical and clinical studies have been performed by an unreliable administration route, the correct approach of oxygen-ozonetherapy may break a vicious circle. Messengers, released by a precise interaction ex vivo of the patient's blood with an equivalent calculated dose of ozone (0.42-0.84 mM), react with a variety of cells after blood infusion and restore a number of functions went astray. This paper aims to open a debate on this new therapy for improving the prognosis of diabetes."], "CopyrightInformation": "Copyright \u00a9 2010 Diabetes India. Published by Elsevier Ltd. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, University of Siena, Via A. Moro 2, 53100 Siena, Italy. bocci@unisi.it"}], "Identifier": [], "LastName": "Bocci", "ForeName": "Velio", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zanardi", "ForeName": "Iacopo", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huijberts", "ForeName": "Maya S P", "Initials": "MS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Travagli", "ForeName": "Valter", "Initials": "V"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Diabetes Metab Syndr", "NlmUniqueID": "101462250", "ISSNLinking": "1871-4021"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism", "therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["physiology"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["methods", "trends"], "DescriptorName": "Oxygen Inhalation Therapy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2012", "Month": "7", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "2013", "Month": "8", "Day": "21", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["22814842", "10.1016/j.dsx.2010.05.014", "S1871-4021(10)00037-8"]}}], "PubmedBookArticle": []}